Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature

Purpose of Review This study aims to examine the treatments currently available for Tourette syndrome (TS) and to discuss evolving therapies, spanning behavioral, pharmacologic, complementary and alternative medicine, and neuromodulation approaches. Recent Findings Behavioral therapies have undergone several modifications to improve accessibility, including transitioning to a virtual format which is particularly important in the current pandemic. There are several recent or ongoing pharmacologic studies that have shown promise including the selective D1 receptor antagonist ecopipam and various cannabinoid compounds. Adaptive DBS may enable the physiologic markers of tics to determine stimulation parameters and improve tic outcomes related to neuromodulation. In recent years, there has been a wealth of research across multiple treatment domains in the TS field. This review highlights exciting and new potential options for the future treatment of patients with TS.

Automated summary

This article reviews the current treatments for Tourette syndrome (TS) and discusses emerging therapies. Recent studies have shown promising results in behavioral therapies, pharmacological treatments, and neuromodulation approaches. These new options may provide hope for future treatment of TS patients.